Keywords: Parkinson's Disease, Neurodegeneration
Motivation: There is a need for reliable prognostic biomarkers to guide Parkinson’s disease (PD) symptom management.
Goal(s): To assess whether fractal dimension (FD), as a measure of (sub)-cortical boundary complexity, can distinguish patients with PD from healthy controls and explain variance in motor symptom severity.
Approach: T1-weighted MRI data from six sites, age-matched between PD and controls, were analyzed. FD was compared between the two groups, and correlations were drawn with pre-operative motor symptom scores in the OFF-medication state.
Results: FD significantly distinguished PD from controls and correlated with motor symptom severity in nine distributed brain regions.
Impact: This study confirms regional fractal dimension (FD)—a measure of sub-(cortical) boundary complexity—as a biomarker of Parkinson’s disease diagnosis and severity. FD could be used to improve clinical decision-making including patient-specific treatment planning.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords